Skip to main content

Web Content Syndication – Web Pages

Informative text from the FDA to place on your tobacco prevention website.
Back to results

webpage

Submit Comments on Tobacco Products


Preview Text for Your Web Page

The following text is a preview of content you can place on your website. After you save it to Your Web Content, we will provide you with a line of code to publish on your website. The text will appear in the style of your website.

Make your voice heard and be part of our ongoing effort to improve public health in the United States.

We solicit information and comments, announced in the Federal Register and posted in dockets on Regulations.gov, from concerned citizens, industry, and organizations on a wide range of issues related to implementation of the Tobacco Control Act.

Submit Comments

Requests for Nominations: Tobacco Products Scientific Advisory Committee
Docket No:
FDA-2020-N-1371
Submit Nominations By: June 22, 2020
Summary: The Food and Drug Administration is requesting nominations for a nonvoting representative of the tobacco growers to serve on the Tobacco Products Scientific Advisory Committee, in the Center for Tobacco Products.  FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups.  A nominee may either be self-nominated or nominated by an organization.

Request for Information on Vaping Products Associated With Lung Injuries
Docket No: FDA-2020-N-0597
Comment Period End Date: June 19, 2020
Summary: The Food and Drug Administration (FDA or the Agency) is extending the comment period for the request for information (RFI) entitled “Request for Information on Vaping Products Associated with Lung Injuries” that appeared in the Federal Register on February 18, 2020. In the RFI, FDA opened a docket to obtain data and information related to the use of vaping products that are associated with recent lung injuries. The RFI responds to direction from Congress to gather information that could help identify and evaluate additional steps the Agency could take to “address the recent pulmonary illnesses reported to be associated with the use of e-cigarettes and vaping products.”The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.


What makes an effective and useful comment?

Our decisions are based on science and law. We look for logic, good science, and other evidence in the comments we evaluate.

  • Provide a clear statement of whether you support or oppose the proposed rule or guidance.
  • Include any of the following that support your position:
    • data
    • research
    • analysis
  • Read more tips for submitting effective comments on the regulations.gov website.

Your role in shaping tobacco regulation

Our regulatory process generally follows these steps:

  1. Rule/Regulation Proposed
    We publish a proposed rule in the Federal Register.
  2. Public Comments Considered
    Our proposals generally have a 60-90 day review period.
  3. Final Rule Issued
    After considering all comments, we issue a final rule.
  4. Compliance with New Rule Enforced
    We must ensure that retailers and businesses comply with the regulation.

Additional Resources


Audience: Health Professional, Retailer, Manufacturer

Topics: Regulations/Compliance/Enforcement, Science/Research, prevention

Source: https://www.fda.gov/tobacco-products/products-guidance-regulations/submit-comments-tobacco-products